| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.84B | 1.78B | 3.04B | 4.06B | 4.55B | 2.22B |
| Gross Profit | 320.44M | 306.31M | 438.33M | 480.29M | 613.14M | 208.99M |
| EBITDA | 97.46M | 96.69M | 217.83M | 431.02M | 415.34M | 162.22M |
| Net Income | 37.78M | 41.20M | 138.28M | 297.63M | 274.81M | 79.94M |
Balance Sheet | ||||||
| Total Assets | 1.26B | 1.24B | 1.20B | 1.10B | 1.16B | 912.54M |
| Cash, Cash Equivalents and Short-Term Investments | 136.94M | 291.68M | 349.64M | 151.68M | 64.75M | 18.36M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 223.31M | 312.01M |
| Total Liabilities | 46.53M | 42.24M | 38.44M | 49.94M | 381.44M | 381.52M |
| Stockholders Equity | 1.21B | 1.20B | 1.16B | 1.05B | 779.37M | 531.03M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -73.57M | 221.09M | 319.87M | 145.34M | -19.08M |
| Operating Cash Flow | 0.00 | -1.92M | 268.07M | 349.72M | 164.37M | -5.57M |
| Investing Cash Flow | 0.00 | -56.71M | -33.29M | -15.30M | 31.08M | -13.21M |
| Financing Cash Flow | 0.00 | -3.96M | -32.19M | -260.40M | -152.34M | 40.48M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ₹1.37B | 13.22 | ― | ― | 29.24% | 75.16% | |
67 Neutral | ₹1.67B | 15.66 | ― | ― | ― | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
57 Neutral | ₹1.81B | 28.65 | ― | 0.28% | 19.61% | 21.47% | |
53 Neutral | ₹1.90B | 64.12 | ― | ― | 119.41% | -35.45% | |
51 Neutral | ₹984.29M | 22.71 | ― | 0.58% | ― | ― | |
49 Neutral | ₹1.08B | -5.31 | ― | ― | -41.73% | -37.19% |
Sarthak Metals Limited has announced the successful passage of resolutions through a postal ballot, as detailed in their e-voting results. The resolutions, which were approved by the requisite majority, reflect compliance with SEBI’s Listing Regulations and demonstrate the company’s commitment to transparent governance practices.
Sarthak Metals Ltd has announced amendments to its Memorandum of Association, following shareholder approval via a postal ballot. The company is expanding its business scope to include biotechnological products, enzymes, bio-based chemicals, and pharmaceuticals, which could diversify its operations and enhance its market positioning. Additionally, the re-appointment of Mr. Sunil Dutt Bhatt as an Independent Director was approved, which may provide continuity in leadership and strategic direction.